- Condition: Dyslipidemia
Interventions: Drug: Ezetimibe/simvastatin; Drug: Other Statin
Sponsors: Merck; Merck
Not yet recruiting - verified May 2012 - Condition: Sitosterolemia
Intervention: Drug: Ezetimibe
Sponsors: University of Manitoba; University of Manitoba
Recruiting - verified April 2012 - Condition: Hypercholesterolaemia
Interventions: Drug: 10mg Ezetimibe; Drug: 10 mg Ezetimibe - wash out period
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified May 2012 - Condition: Alopecia Areata
Interventions: Drug: vytorin; Drug: vytorin
Sponsors: University of Miami; University of Miami
Recruiting - verified January 2012 - Condition: Cardiovascular Diseases
Interventions: Drug: AMR101; Drug: Placebo
Sponsors: Amarin Pharma Inc.; Amarin Pharma Inc.
Recruiting - verified March 2012 - Condition: Coronary Artery Disease
Interventions: Drug: Ezetimibe; Drug: Nutraceuticals
Sponsors: University of Roma La Sapienza; University of Roma La Sapienza
Not yet recruiting - verified December 2011 - Condition: Hypercholesteremia
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Completed - verified February 2012 - Conditions: Type 2 Diabetes; Inflammation
Interventions: Drug: Simvastatin 80 mg; Drug: Sim10/Eze10; Drug: Placebo
Sponsors: University of Heidelberg; University of Heidelberg
Completed - verified August 2011 - Conditions: Hypercholesterolemia; Dyslipidemia
Interventions: Drug: Rosuvastatin + Ezetimibe; Drug: Simvastatin + Ezetimibe
Sponsors: Ache Laboratorios Farmaceuticos S.A.; Ache Laboratorios Farmaceuticos S.A.
Not yet recruiting - verified August 2011 - Conditions: Dyslipidemia; Hypercholesterolemia
Intervention:
Sponsors: Merck; Merck
Active, not recruiting - verified September 2011 - Condition: ST-Segment Elevation Myocardial Infarction
Interventions: Drug: Ezetimibe; Drug: Placebo
Sponsors: Odense University Hospital; Odense University Hospital
Recruiting - verified June 2011 - Conditions: Diabetes Mellitus Type 2; Hypercholesterolemia
Interventions: Drug: ezetimibe; Drug: simvastatin; Drug: Ezetimibe 10/Simvastatin 20
Sponsors: University Hospital Freiburg; University Hospital Freiburg; Essex Pharma GmbH
Completed - verified February 2008 - Condition: Hypercholesterolemia
Intervention: Drug: Ezetimibe
Sponsors: Merck; Merck
Completed - verified February 2012 - Condition: Hyperlipidemia
Interventions: Biological: AMG 145; Other: Ezetimibe; Other: Placebo
Sponsors: Amgen; Amgen
Active, not recruiting - verified April 2012 - Condition: Hyperlipidemia
Interventions: Biological: AMG 145; Other: Ezetimibe; Other: Placebo
Sponsors: Amgen; Amgen
Active, not recruiting - verified April 2012 - Condition: Hypercholesterolemia
Interventions: Drug: Atorvastatin; Drug: Ezetimibe; Drug: Ezetimibe/atorvastatin; Drug: Placebo to atorvastatin; Drug: Placebo to ezetimibe; Drug: Placebo to ezetimibe/atorvastatin
Sponsors: Merck; Merck
Completed - verified May 2012 - Condition: Hypercholesterolemia
Interventions: Drug: Atorvastatin; Drug: Ezetimibe; Drug: Ezetimibe/atorvastatin; Drug: Placebo to atorvastatin; Drug: Placebo to ezetimibe; Drug: Placebo to ezetimibe/atorvastatin
Sponsors: Merck; Merck
Active, not recruiting - verified April 2012


